Quadrant Capital Group’s Ventyx Biosciences VTYX Stock Holding History

Quadrant Capital Group’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-794	Closed	-$7.17K	–	2814
2025 Q4	$7.17K	Buy	+794	New	+$5.93K	﹤0.01%	2287
2024 Q1	–	Sell	-42	Closed	-$104	–	2779
2023 Q4	$104	Hold	42	–	–	﹤0.01%	2681
2023 Q3	$1.46K	Hold	42	–	–	﹤0.01%	2449
2023 Q2	$1.38K	Hold	42	–	–	﹤0.01%	2469
2023 Q1	$1.41K	Hold	42	–	–	﹤0.01%	2488
2022 Q4	$1.38K	Sell	42 -20	-32%	-$592	﹤0.01%	2484
2022 Q3	$2K	Hold	62	–	–	﹤0.01%	2441
2022 Q2	$1K	Sell	62 -38	-38%	-$568	﹤0.01%	2472
2022 Q1	$1K	Buy	+100	New	+$1.34K	﹤0.01%	2413

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quadrant Capital Group's VTYX Position: Q1 2026 in Review

Quadrant Capital Group sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 794 shares — an estimated $7.17K sold.

Quadrant Capital Group first reported a position in VTYX in Q1 2022 and held it in 9 quarters. The position peaked at $7.17K in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Quadrant Capital Group reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Quadrant Capital Group sold 794 Ventyx Biosciences shares in Q1 2026, an estimated $7.17K.
Quadrant Capital Group first reported a position in Ventyx Biosciences in Q1 2022 and held it in 9 quarters.
Quadrant Capital Group's Ventyx Biosciences position peaked at $7.17K in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.